Clinical Trials Directory

Trials / Unknown

UnknownNCT03122938

Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women

Effect of Daily Bovine Lactoferrin Supplementation on Fetal Development and Iron Metabolism in Healthy Pregnant Women: A Randomized Double-blind Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Beingmate Baby & Child Food Co Ltd . · Academic / Other
Sex
Female
Age
20 Years – 34 Years
Healthy volunteers
Accepted

Summary

To assess the effects of a lactoferrin supplemented formula on fetal development , iron metabolism and immunity in healthy pregnant women. One hundred and twenty healthy pregnant women (24\<gestational weeks\<26) are enrolled and randomly assigned to lactoferrin-supplemented formula group (active group) or normal formula group (control group, without lactoferrin supplementation). Subjects allocated in active group consume lactoferrin supplemented formula (85mg lactoferrin per 100g) 3 times a day (81g totally), while those in control group consume formula without lactoferrin supplementation (\<6mg lactoferrin per 100g formula) according to the same schedule. Routine blood test including hemoglobin and serum ferritin, and food frequency questionnaire-based review and 24h\*3 dietary record are performed every 4 weeks during intervention until delivery. Body weight of newborns are recorded after delivery. The differences in iron deficiency anemia morbility of pregnant women and anthropometric measurements of newborns between groups would be analyzed after completion of this study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTlactoferrin-supplemented formulaSubjects consume lactoferrin-supplemented formula (85mg lactoferrin per 100g) 3 times a day (81g totally).
DIETARY_SUPPLEMENTformula without lactoferrin supplementationSubjects consume formula without lactoferrin supplementation (\<6mg lactoferrin per 100g formula) 3 times a day (81g totally).

Timeline

Start date
2016-04-01
Primary completion
2017-04-01
Completion
2017-05-01
First posted
2017-04-21
Last updated
2017-04-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03122938. Inclusion in this directory is not an endorsement.